146 related articles for article (PubMed ID: 31275061)
1. Tissue Inhibitor of Metalloproteinase-2 Polymorphisms and Risk for HIV-Associated Neurocognitive Disorder.
Singh H; Jadhav S; Samani D; Nain S
Mediators Inflamm; 2019; 2019():8278095. PubMed ID: 31275061
[TBL] [Abstract][Full Text] [Related]
2. Effect of matrix metalloproteinase-21 (572C/T) polymorphism on HIV-associated neurocognitive disorder.
Singh H; Samani D; Nambiar N; Ghate MV; Gangakhedkar RR
APMIS; 2018 Apr; 126(4):329-336. PubMed ID: 29575199
[TBL] [Abstract][Full Text] [Related]
3. [Association of SNPs in the promoter of MMP-2 and TIMP-2 genes with epithelial ovarian cancer].
Li XL; Kang S; Zhao XW; Zhang XJ; Zhou RM; Wang N; Jia JH; Zhao J; Li Y
Yi Chuan; 2008 Apr; 30(4):455-62. PubMed ID: 18424416
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of MMP-8 gene polymorphisms in HIV-infected individuals and its association with HIV-associated neurocognitive disorder.
Singh H; Samani D; Nambiar N; Ghate MV; Gangakhedkar RR
Gene; 2018 Mar; 646():83-90. PubMed ID: 29292194
[TBL] [Abstract][Full Text] [Related]
5. [Study on the association of SNPs of MMP-2 and TIMP-2 genes with the risk of endometriosis and adenomyosis].
Zhao XW; Li Y; Wang N; Zhao J; Li XL; Liu Q; Jia JH; Yang ZF; Kang S
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2008 Jun; 25(3):280-3. PubMed ID: 18543216
[TBL] [Abstract][Full Text] [Related]
6. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
Banday MZ; Sameer AS
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
[No Abstract] [Full Text] [Related]
7. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
8. MMP-2 and TIMP-2 gene polymorphisms and susceptibility to atrial fibrillation in Chinese Han patients with hypertensive heart disease.
Gai X; Zhang Z; Liang Y; Chen Z; Yang X; Hou J; Lan X; Zheng W; Hou J; Huang M
Clin Chim Acta; 2010 May; 411(9-10):719-24. PubMed ID: 20138860
[TBL] [Abstract][Full Text] [Related]
9. Occurrence of Interleukin-2 (330 G/T) Promoter Polymorphism in ARV associated hepatotoxicity.
Singh H; Nambiar N; Samani D; Gangakhedkar RR
Curr Mol Med; 2019; 19(3):206-215. PubMed ID: 30973108
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of polymorphism of matrix metalloproteinase-2 and metalloproteinase tissue inhibitor-2 promoters in breast cancer in Tunisia: case-control study.
Ben Néjima D; Ben Zarkouna Y; Gammoudi A; Manai M; Boussen H
Tumour Biol; 2015 May; 36(5):3815-22. PubMed ID: 25656607
[TBL] [Abstract][Full Text] [Related]
11. Role of MMP-13-77A/G polymorphism in HIV-associated neurocognitive disorders patients.
Singh H; Dhotre K
Microb Pathog; 2022 Nov; 172():105740. PubMed ID: 36055571
[TBL] [Abstract][Full Text] [Related]
12. Role of APOC3 3238C/G polymorphism in HIV-associated neurocognitive disorder.
Singh H; Dhotre K; Shyamveer ; Namdev G; Mahajan SD; Parvez MK; Al-Dosari MS
Microb Pathog; 2023 Jun; 179():106107. PubMed ID: 37044204
[TBL] [Abstract][Full Text] [Related]
13. TIMP-2 gene polymorphism is associated with intracerebral hemorrhage.
Reuter B; Bugert P; Stroick M; Bukow S; Griebe M; Hennerici MG; Fatar M
Cerebrovasc Dis; 2009; 28(6):558-63. PubMed ID: 19844095
[TBL] [Abstract][Full Text] [Related]
14. Higher risk of matrix metalloproteinase (MMP-2, 7, 9) and tissue inhibitor of metalloproteinase (TIMP-2) genetic variants to gallbladder cancer.
Sharma KL; Misra S; Kumar A; Mittal B
Liver Int; 2012 Sep; 32(8):1278-86. PubMed ID: 22621753
[TBL] [Abstract][Full Text] [Related]
15. Impact of variants of MMP-7(-181A>G) gene in susceptibility to the development of HIV-associated neurocognitive disorder and its severity.
Singh H; Marathe SD; Nain S; Nema V; Angadi M; Bapat SS; Ghate MV; Gangakhedkar RR
APMIS; 2016 Nov; 124(11):966-972. PubMed ID: 27538541
[TBL] [Abstract][Full Text] [Related]
16. Role of MMP-2(-1306 C/T) and TIMP-2(-418G/C) Polymorphism in Chinese Han Patients with Acne Vulgaris.
Gao R; Yu H; Zhao Q; Wang S; Bai B
Biomed Res Int; 2019; 2019():2364581. PubMed ID: 31032338
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase-2 promoter and tissue inhibitor of metalloproteinase-2 gene polymorphisms in non-Hodgkin's lymphoma.
Diao LP; Ma H; Wei GC; Li T; Liu HS; Liu LH; Wu LL; Zhao GM; Gao YH
Int J Cancer; 2012 Sep; 131(5):1095-103. PubMed ID: 22020421
[TBL] [Abstract][Full Text] [Related]
18. Promoter polymorphism MMP-1 (-1607 2G/1G) and MMP-3 (-1612 5A/6A) in development of HAND and modulation of pathogenesis of HAND.
Singh HO; Marathe SD; Nain S; Samani D; Nema V; Ghate MV; Gangakhedkar RR
J Biosci; 2017 Sep; 42(3):481-490. PubMed ID: 29358561
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
Chen YC; Ho WM; Lee YS; Chen HW; Chen CM
PLoS One; 2015; 10(11):e0142482. PubMed ID: 26551785
[TBL] [Abstract][Full Text] [Related]
20. TIMP-2 G-418C polymorphism and cancer risk: A meta-analysis.
Zhang S; Gao X; Yang J; Ji Z
J Cancer Res Ther; 2015; 11(2):308-12. PubMed ID: 26148591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
